What does issuance of warrants to purchase common stock mean?

Captures the accounting value assigned to warrants issued by the company, typically recorded as an adjustment to additional paid-in capital. This reflects the issuance of derivative instruments that grant holders the right to purchase common stock at a specified price.

NovaGold Resources NG Issuance of warrants to purchase common stock

Issuance of warrants to purchase common stock at other companies

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

NovaGold ResourcesNG

$9.9M—

KEE

Keel Infrastructure Corp. Common StockKEEL

$11.48M—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Applied DigitalAPLD

$121.2M+232%

IDEAYA Biosciences, Inc.IDYA

$0—

Other financials

Income statement

See full

Revenue-—

Operating income-$11.8M-24.9%

Net income-$25.5M-7.7%

EPS (diluted)-$0.03—

Balance sheet

See full

Cash & equivalents$78.2M-73.4%

Total debt$173.6M+9.4%

Total equity$421.0M+155%

Total assets$598.7M+81.8%

Cash flow

See full

Operating cash flow-$6.4M-293%

CapEx--100%

Free cash flow-$4.0M-181%

Valuation

See full

Market cap$3.17B+167%

Returns & leverage

See full

Return on equity-30.1%—

Debt / equity0.4×-0.5×

Current ratio112.8×+36.1×

Where this comes from

Reported directly by NovaGold Resources in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: NovaGold Resources’s 10-K, filed January 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovaGold Resources's issuance of warrants to purchase common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovaGold Resources's issuance of warrants to purchase common stock?: NovaGold Resources (NG) reported issuance of warrants to purchase common stock of $9.9M in Q3 2025.
What does issuance of warrants to purchase common stock mean?: Captures the accounting value assigned to warrants issued by the company, typically recorded as an adjustment to additional paid-in capital. This reflects the issuance of derivative instruments that grant holders the right to purchase common stock at a specified price.